Literature DB >> 31845231

Microsurgical Treatment of Epilepsy with Parenchymal Neurocysticercosis.

Yu-Tang Tan1, Suo-Jun Zhang1, Kai Shu1, Ting Lei1, Hong-Quan Niu2.   

Abstract

Parenchymal neurocysticercosis is the most common form of neurocysticercosis in the central nervous system (CNS), which mainly causes epilepsy and usually responses well to routine medications. However, there are appreciable cases of relapses refractory to medical treatment. We investigated microsurgical treatment of epilepsy with parenchymal neurocysticercosis. Nine cases of epilepsy caused by parenchymal neurocysticercosis from 2002 to 2018 were analyzed retrospectively. Cysts in 7 cases were completely removed. No case died of operation and no new dysfunction of the nervous system was observed after surgery. Among the other 9 cases, 8 cases became seizure-free or controlled by medicine according to the postoperative follow-up for 6 months to 9 years. One case was lost for follow-up. It was suggested that epilepsy with parenchymal neurocysticercosis can usually be controlled after routine medications. However, surgery is still indicated in some cases and careful microsurgery is associated with satisfactory clinical outcomes in appropriately selected cases.

Entities:  

Keywords:  epilepsy; microsurgery; neurocysticercosis; parenchymal cysticercosis

Mesh:

Year:  2019        PMID: 31845231     DOI: 10.1007/s11596-019-2132-1

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  42 in total

1.  Relationship between cysticercosis and epilepsy.

Authors:  L Monteiro; J Lopes; A Martins da Silva
Journal:  Epilepsia       Date:  1999-10       Impact factor: 5.864

Review 2.  Presurgical evaluation of epilepsy.

Authors:  F Rosenow; H Lüders
Journal:  Brain       Date:  2001-09       Impact factor: 13.501

3.  Cysticercosis Epilepsy.

Authors:  W Blyth
Journal:  Br Med J       Date:  1941-03-15

Review 4.  Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis.

Authors:  O H Del Brutto; N H Wadia; M Dumas; M Cruz; V C Tsang; P M Schantz
Journal:  J Neurol Sci       Date:  1996-10       Impact factor: 3.181

Review 5.  Clinical manifestations, diagnosis, and treatment of neurocysticercosis.

Authors:  Julio Sotelo
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

6.  Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis.

Authors:  O H Del Brutto
Journal:  Neurology       Date:  1994-09       Impact factor: 9.910

7.  Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial.

Authors:  A Carpio; E A Kelvin; E Bagiella; D Leslie; P Leon; H Andrews; W A Hauser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-05-21       Impact factor: 10.154

8.  Cysticercosis as a major risk factor for epilepsy in Burundi, east Africa.

Authors:  Georges Nsengiyumva; Michel Druet-Cabanac; Bienvenue Ramanankandrasana; Bernard Bouteille; Léopold Nsizabira; Pierre-Marie Preux
Journal:  Epilepsia       Date:  2003-07       Impact factor: 5.864

Review 9.  Surgical management of neurocysticercosis.

Authors:  Vedantam Rajshekhar
Journal:  Int J Surg       Date:  2010-01-04       Impact factor: 6.071

10.  Public health implications of cysticercosis acquired in the United States.

Authors:  Frank Sorvillo; Patricia Wilkins; Shira Shafir; Mark Eberhard
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.